Kezar Life Sciences, Inc. — Director's Dealing 2018

Jun 20, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2018-06-20

Reporting Person: STEYER THOMAS F (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$		Common Stock (210326)		Indirect
Series B Convertible Preferred Stock	$		Common Stock (125927)		Indirect

Footnotes

F1: Not Applicable

F2: 1-for-1